-
Ashland to Buy Pharmachem for $660 Million
Ashland has agreed to acquire New Jersey-based Pharmachem Laboratories, a manufacturer of supplements and specialty ingredients for the wellness and p...
2017-04-24 09:54 -
The World's Biggest Drugmaker Just Pulled Back the Curtain on Drug Pricing
The world's largest drugmaker just gave us a better idea of how drug price hikes impact its business.
2017-04-21 09:39 -
China Pharma Poised for Explosive Growth, Novartis CEO Says
As drugmakers face growth challenges in the U.S. and other developed countries, China is looking more enticing to one CEO. Novartis chief Joe Jimenez ...
2017-04-21 09:22 -
Russian & Swedish Scientists Slow Down Mice Aging with Synthetic Antioxidant
A new experiment conducted by a joint team of Russian and Swedish scientists has produced groundbreaking results in slowing down the ageing process of...
2017-04-18 15:17 -
FDA Approves Two Hepatitis C Drugs - Sovaldi and Harvoni - for Pediatric Patient
The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to tre...
2017-04-18 10:14 -
Is Novartis looking at divesting some of its respiratory drugs? Drugmaker says n
A year ago, Novartis inked a high-profile partnership with tech giant Qualcomm to develop a smart inhaler, in a clear bid to compete with its chief ri...
2017-04-01 10:37 -
Post-disastrous Valeant investment, soul-searching Ackman reflects on lessons le
One-time Valeant enthusiast and hedge fund manager Bill Ackman has already lamented his huge bet on the now-imploded drugmaker as “one very big mista...
2017-04-01 10:34 -
Merck KGaA disses Ocrevus-Rebif price comparison as 'misleading and oversimplifi
Roche surprised industry watchers on Tuesday when it placed a $65,000 list price on multiple sclerosis blockbuster-to-be Ocrevus, sparking comparisons...
2017-04-01 10:31 -
Vertex trumpets data for new CF combo it hopes can outdo sluggish Orkambi
Vertex’s cystic fibrosis combo, Orkambi, hasn’t exactly torn up the market since hitting the scene in 2015. Now, though, the company has a new combo...
2017-04-01 10:27 -
Pharma's most-valuable brands? J&J, Pfizer and Merck. Valeant, not so much
U.S. pharma brands jumped in value almost across the board in Brand Finance's annual look at the nation’s most valuable. The lone exception? Valeant ...
2017-04-01 10:13
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- Glenmark Recalls Over 110000 B... Aug 24, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
- Wanhua Chemical Boosts TDI Cap... Aug 24, 2025
Related Products
Related Producers
